Abbott LaboratoriesABTNYSE
Loading
Operating Income ScalingExpanding
Percentile Rank86
3Y CAGR-1.3%
5Y CAGR+8.8%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
-1.3%/yr
vs +21.4%/yr prior
5Y CAGR
+8.8%/yr
Recent deceleration
Acceleration
-22.7pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $8.05B | +17.9% |
| 2024 | $6.83B | +6.1% |
| 2023 | $6.43B | -23.0% |
| 2022 | $8.36B | -9.1% |
| 2021 | $9.20B | +73.9% |
| 2020 | $5.29B | +15.2% |
| 2019 | $4.59B | +19.4% |
| 2018 | $3.84B | +94.9% |
| 2017 | $1.97B | -39.3% |
| 2016 | $3.25B | - |